AFP and neoplasm: Many other models were designed by introducing appropriate biomarkers such as serum AFP, HBsAg, cytoskeleton-associated protein 2, plasma fibrinogen which showed improved prognostic power for tumor recurrence and provided a wider perspective to consider for RR indication [21, 22, 23, 24, 25].